دورية أكاديمية
Efficacy and Safety of CT-P13 in Inflammatory Bowel Disease after Switching from Originator Infliximab: Exploratory Analyses from the NOR-SWITCH Main and Extension Trials
| العنوان: | Efficacy and Safety of CT-P13 in Inflammatory Bowel Disease after Switching from Originator Infliximab: Exploratory Analyses from the NOR-SWITCH Main and Extension Trials |
|---|---|
| المؤلفون: | Jørgensen, Kristin K.Aff1, Goll, Guro L., Sexton, Joe, Bolstad, Nils, Olsen, Inge C., Asak, Øivind, Berset, Ingrid P., Blomgren, Ingrid M., Dvergsnes, Katrine, Florholmen, JonAff9, Aff10, Frigstad, Svein O.Aff11, Aff12, Henriksen, Magne, Hagfors, Jon, Huppertz-Hauss, Gert, Haavardsholm, Espen A.Aff2, Aff12, Klaasen, Rolf A., Moum, BjørnAff12, Aff16, Noraberg, Geir, Prestegård, Ulf, Rydning, Jan H.Aff1, Aff19, Sagatun, Liv, Seeberg, Kathrine A., Torp, Roald, Vold, Cecilia, Warren, David J., Ystrøm, Carl M., Lundin, Knut E. A.Aff12, Aff25, Aff26, Kvien, ToreAff2, Aff12, Jahnsen, JørgenAff1, Aff12 |
| المصدر: | BioDrugs. 34(5):681-694 |
| قاعدة البيانات: | Springer Nature Journals |
Find this article in full text from Springer Verlag. 
Full Text Finder | تدمد: | 11738804 1179190X |
|---|---|
| DOI: | 10.1007/s40259-020-00438-7 |